ArticleThe Biochemical journal2026
A non-catalytic interaction surface mediates recognition of spliceosomal factors by the Toxoplasma gondii cyclophilin TgCyp23.
Article in The Biochemical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The spliceosome is emerging as a key regulatory hub in Toxoplasma gondii, yet the molecular basis of spliceosomal protein interactions remains largely unexplored. TgCyp23, a predicted nuclear cyclophilin (Cyp) from T. gondii, shares sequence similarity and catalytic properties with the human spliceosomal cyclophilin H (hCypH) that interacts with the splicing factors PRP4 and PRP18. Here, we investigated whether TgCyp23 engages in analogous interactions with the T. gondii orthologs TgPRP4 and TgPRP18 using peptides corresponding to their predicted Cyp-binding regions. High-resolution crystal structures of TgCyp23 in complex with a TgPRP4-derived peptide, including a ternary complex with the Cyp inhibitor cyclosporin A, reveal that spliceosomal partner recognition occurs outside the catalytic site, which remains fully accessible. NMR analyses extend this binding mode to TgPRP18, demonstrating that peptides derived from both spliceosomal factors engage the same surface in solution. Isothermal titration calorimetry shows that TgCyp23 binds both peptides with low- to mid-micromolar affinity, while circular dichroism and molecular dynamics support a folding-upon-binding mechanism. Notably, binding of either peptide does not affect the peptidyl-prolyl isomerase activity of TgCyp23 or its sensitivity to cyclosporin A, indicating that partner recognition and catalytic function are mechanistically separable. Together, these findings identify a non-catalytic interaction surface in TgCyp23 that mediates recognition of spliceosomal factors. The similar interaction mode observed for TgCyp23 and hCypH suggests that spliceosomal partner recognition may be conserved and supports a role for TgCyp23 as a spliceosome-associated Cyp in T. gondii, providing a structural framework for understanding Cyp interactions within the parasite spliceosome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.